Other lipid-lowering therapies include: Ezetimibe : Reduces LDL cholesterol by approximately 1520% by inhibiting intestinal cholesterol absorption Bempedoic acid : Lowers LDL cholesterol by 15-25%, often used with ezetimibe when statins are contraindicated or not tolerated PCSK9 inhibitors : Achieve dramatic LDL reductions of 5060%, reserved for patients with very high cardiovascular risk or familial hypercholesterolaemia Fibrates : Primarily target triglycerides (reductions of 3050%) with modest effects on LDL cholesterol Icosapent ethyl : A prescription-grade omega-3 fatty acid that may be used in selected high-risk patients
That single mechanism explains nearly all of the snacking advice below: a slower-emptying stomach fills faster, tolerates fat poorly early on, and rewards small, nutrient-dense portions
Because these drugs have such a small margin between therapeutic and toxic doses, even slight changes in absorption can heighten risks
One large meal represents roughly 24 hours of caloric surplus
That flexibility may make it easier for people who already take medications on a strict schedule
Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study